Hologic to Acquire Focal Therapeutics for $125 Million, Strengthening Breast Surgery Franchise

Hologic to Acquire Focal Therapeutics for $125 Million, Strengthening Breast Surgery Franchise


Sep 26, 2018--Hologic, Inc. , a global leader in women's health, announced today that it has signed a definitive agreement to acquire Focal Therapeutics, a privately-held company, for $125 million in cash. In conjunction with Hologic's recent acquisition of Faxitron Bioptics, Focal strengthens the Company's position in the rapidly growing market for breast conserving surgery.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога